Why Investors Should Follow Fed Chair Powell's Lead on the War in Iranfool.comJerome Powell asserted a "wait-and-see" approach regarding the impact of the Iran war.
For Pharvaris Investors, the Director's Sale Matters Less Than What's Coming Nextfool.comThis biopharma innovator in rare disease therapies reported a notable insider sale amid a year of strong stock performance.
3 Phenomenal AI Stocks for Maximum Upsidefool.comNvidia, Nebius, and IonQ each have massive potential, but they come with some risks for shareholders.
SOXX vs. XLK: The Right Pick Depends on What You Already Ownfool.comCompare the trade-offs between concentrated chip exposure and diversified tech holdings, including fees, volatility, and long-term growth outcomes.
Why Biogen Stock Was a Winner on Wednesdayfool.comThe biotech's growth portfolio continues to add to its overall top line.
Bitcoin Is Moving From Trade to Treasury Asset -- Here's Why That Mattersfool.comStarting at the individual level first, the leading cryptocurrency's evolution hasn't been like typical financial assets.
